Loading logo

Glipizide Impurities

Glipizide is an oral antidiabetic medication belonging to the sulfonylurea class, primarily used to manage type 2 diabetes mellitus by stimulating insulin release from pancreatic beta cells. It helps lower blood glucose levels and is typically prescribed when diet and exercise alone are insufficient for glycemic control. Ensuring the pharmaceutical purity of Glipizide is essential for maintaining its therapeutic effectiveness, minimizing adverse effects, and meeting regulatory standards. Impurity profiling is vital to detect and control degradation products or synthesis-related impurities. Here are some of its known impurities listed below.

Showing 1 - 5 of 5 products
Glipizide
Catalogue No : GLIP-OCL-001

CAS No : 29094-61-9

In Stock
Synonyms
1-Cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea
Glipizide Aminoethyl Impurity
Catalogue No : GLIP-OCL-002

CAS No : 2015-16-9

In Stock
Synonyms
4-(2-Aminoethyl)-N-[(cyclohexylamino)carbonyl]benzenesulfonamide
Glipizide EP Impurity A
Catalogue No : GLIP-OCL-003

CAS No : 33288-71-0

In Stock
Synonyms
[2-(4-Sulphamoylphenyl) ethyl] 5-methyl-pyrazine-2-carboxamide
Glipizide EP Impurity C
Catalogue No : GLIP-OCL-004

CAS No : 13554-93-3

In Stock
Synonyms
Ethyl 2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl]carbamate
Glipizide EP Impurity F
Catalogue No : GLIP-OCL-005

CAS No : 192118-08-4

In Stock
Synonyms
[2-[4-(Aminosulfonyl)phenyl]ethyl]carbamic acid ethyl ester